MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · IEX Real-Time Price · USD
At close: May 31, 2023, 4:00 PM
After-hours: May 31, 2023, 7:39 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
|Selling, General & Admin||23.01||18.04||0.11|
|Research & Development||42.05||35.53||0|
|Other Operating Expenses||0||0||0|
|Other Expense / Income||-0.59||0.06||-0.01|
|Shares Outstanding (Basic)||29||233||9|
|Shares Outstanding (Diluted)||29||233||9|
|Free Cash Flow Per Share||-1.90||-0.15||-0.04|
|Depreciation & Amortization||0.01||0||0|
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).